Related Experiment Video
Updated: Nov 18, 2025
Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
Published on: August 17, 2022
How Did We Get a COVID-19 Vaccine in Less Than 1 Year?
E John Wherry1, Elizabeth M Jaffee2, Nicholas Warren3
1Department of Systems Pharmacology and Translational Therapeutics, Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. aribas@mednet.ucla.edu wherry@pennmedicine.upenn.edu.
Abstract:
The successful development of COVID-19 vaccines within an unprecedented short time needs to be followed by rapid vaccine uptake, in particular, in high-risk populations such as patients with cancer. It is important for the scientific research community and cancer physicians to convey the knowledge behind the COVID-19 vaccine development and contribute to build the required trust on their use.
